66. IgA nephropathy Clinical trials / Disease details

Clinical trials : 255 / Drugs : 255 - (DrugBank : 79) / Drug target genes : 35 - Drug target pathways : 137

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02282930 (ClinicalTrials.gov)	March 2015	31/10/2014	Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of Progression	An Open-Label Pilot Study of ACTH in the Treatment of IgA Nephropathy at High Risk of Progression	Progressive IgA Nephropathy;Proteinuria	Drug: ACTH (Acthar) Gel	Mayo Clinic	Mallinckrodt	Completed	18 Years	N/A	All	20	Phase 3	United States
2	NCT02382523 (ClinicalTrials.gov)	February 2015	9/1/2015	Acthar on Proteinuria in IgA Nephropathy Patients	Impact of Acthar on Proteinuria and Disease Progression in IgA Nephropathy Patients With Nephrotic Range Proteinuria	IgA Nephropathy;Proteinuria	Drug: Acthar 80 unit injection	Baylor College of Medicine	NULL	Withdrawn	18 Years	N/A	All	0	Phase 4	United States